Pangenome

Pangenome designates the complete set of genes and genetic variations found across all strains or individuals within a species, encompassing both core genes shared by all members and accessory genes present only in some subsets, providing comprehensive representation of genetic diversity beyond a single reference genome. This concept emerged from microbial genomics where different strains often carry distinct gene clusters influencing virulence, metabolism, and antibiotic resistance.

The biopharmaceutical industry increasingly leverages pangenome approaches to improve target discovery, biomarker identification, and precision medicine strategies by capturing genetic diversity that traditional reference genomes miss. Pangenome analysis supports identification of conserved drug targets across pathogen strains for broad-spectrum therapeutics, detection of strain-specific resistance genes informing antimicrobial development, and improved mapping of sequencing reads enabling more accurate variant calling in diverse populations. In human health, pangenome frameworks help identify population-specific disease-associated variants, guide equitable drug development, and support pharmacogenomic insights into variable drug metabolism and efficacy. As sequencing technologies advance and large-scale genomic datasets expand across ethnicities and geographies, pangenomes become increasingly essential for accurate genomic interpretation and therapeutics reflecting true biological diversity.